In the 1930's when Herman Muller was unable to generate terminally deleted chromosomes in irradiated flies, he reasoned that telomeres, a name he coined for the natural ends of chromosomes, must be essential to maintain stable chromosomes[@R1]. Soon after, Barbara McClintock, working with corn, found that broken chromosomes fuse with other breaks while telomeres do not fuse either with each other or with double strand breaks (DSBs). Together these data suggested that telomeres are important to distinguish natural chromosome ends from DSBs. The cell's ability to distinguish telomeres and DSBs is particularly remarkable given that many proteins involved in sensing and repairing DNA damage also affect telomeres[@R2]. Molecular studies show that telomeres in most organisms consist of repeated DNA in which the strand that comprises the 3′ end of the chromosome is G-rich and extended to form a 3′ single-strand tail. In *Saccharomyces cerevisiae*, the \~300 bp C~1--3~A/TG~1--3~ duplex region and the TG~1--3~ single strand tail are bound respectively by two sequence specific DNA binding proteins, Rap1 and Cdc13[@R3].

Another key function of telomeres is to compensate for the incomplete replication of chromosome ends[@R1]. Due to the biochemical properties of DNA polymerases, a short gap is left at the 5′ ends of newly replicated strands when the most distal RNA primer is removed. In most eukaryotes, this end replication problem is solved by a telomere dedicated reverse transcriptase called telomerase. However, unlike conventional semi-conservative DNA replication, telomerase does not act on each telomere in every cell cycle. Rather in yeasts and mammals, telomerase preferentially elongates the shortest telomeres in the cell[@R4]--[@R6]. In yeast, the frequency and extent of elongation, as well as telomerase processivity, are all greater at telomeres shorter than 125 bps[@R5],[@R7].

The chromatin structure of short telomeres has been investigated to determine if it differs from that of wild-type (WT) telomeres in a manner that might explain why telomerase preferentially lengthens the former. Indeed, two telomerase subunits, Est2 and Est1, bind preferentially to short telomeres, as does the Tel1 kinase[@R8]--[@R10]. Moreover, at a truncated left telomere of chromosome VII, preferential binding of Est2 and Est1 is dependent on Tel1, the yeast equivalent of the ATM checkpoint kinase, and Tel1 binding requires the carboxyl end of Xrs2[@R8], a subunit of the heterotrimeric Mre11 complex. Tel1 is also required for processive telomerase action at short (≤125 bps) telomeres[@R7].

Here we show that the MRX complex, comprised of Mre11, Rad50, and Xrs2, bound preferentially to short telomeres, a result that can explain how Tel1 and hence telomerase are targeted to short telomeres. However, this result raises the question of how MRX recognizes short telomeres. Rap1 and its associated proteins, Rif1 and Rif2, two negative regulators of telomerase, are brought to telomeres in a mutually exclusive manner by protein-protein interactions with the carboxyl terminus of Rap1[@R3]. As Rap1 binding sites are distributed at \~18 bp intervals throughout the yeast telomere[@R11], by definition telomeres lose Rap1 binding sites as they shorten. Thus, differences in Rif1 and/or Rif2 occupancy are an appealing explanation for how cells distinguish short from WT length telomeres.

Here we report that Rif2 (but not Rif1) was less abundant at two natural telomeres shortened from their ends by incomplete replication. In addition, Tel1 no longer bound preferentially to short telomeres in *rif2Δ* (but not *rif1Δ*) cells. Thus, Rif1 and Rif2 act by different mechanisms to inhibit telomerase, and the two proteins appear to be distributed differently along the length of the telomere. Likewise, when a DSB is introduced adjacent to a 162 bp tract of telomeric DNA, Rif2 inhibits telomere addition to the break while Rif1 has a much more modest effect, again suggesting that the two proteins act by different mechanisms[@R12]. Moreover, while the major checkpoint kinase Mec1 bound robustly to an induced DSB, Mec1 binding was ≥140 times lower at a short telomere in a *tel1Δ* strain where Mec1 is required for telomerase activity[@R13]--[@R14]. Replication protein A (RPA), a sequence non-specific, single strand DNA binding protein with essential roles in DNA replication and repair, showed a pattern similar to that of Mec1: high binding to DSBs and low binding to telomeres. Taken together, our data not only provide a molecular explanation for how short telomeres are targeted for preferential elongation, they also suggest a mechanism for how cells distinguish telomeres from DSBs.

Results {#S1}
=======

Mre11 complex binds preferentially to short VII-L telomeres {#S2}
-----------------------------------------------------------

In previous work, we found that preferential binding of telomerase to a short chromosome VII-L telomere lacking subtelomeric repeats requires the Tel1 kinase, which itself binds preferentially to this telomere[@R8]. Since Tel1 binding to DSBs[@R15]--[@R16] and short telomeres[@R8] requires the carboxyl end of Xrs2, we asked if the MRX complex also binds preferentially to a short telomere. Each of the three MRX subunits, Mre11, Rad50, and Xrs2, was tagged at its carboxyl terminus with 13 MYC epitopes and expressed from its own promoter at its endogenous chromosomal locus.

To examine MRX binding to short versus WT length telomeres, we used a strain with an inducible short telomere[@R4] ([Fig. 1a](#F1){ref-type="fig"}). In the experimental version of this strain ([Fig.1a](#F1){ref-type="fig"}), the left telomere on chromosome VII contains two recognition sites for the site-specific FLP recombinase (FRT sites). FLP is expressed under the control of a galactose inducible promoter. FLP-mediated recombination between the two FRT sites excises a sub-telomeric fragment that reduces the size of the VII-L telomere to only \~100 bps, compared to \~300 bps of telomeric repeats on all other telomeres ([Fig. 1a](#F1){ref-type="fig"}; [Supplementary Fig. 1](#SD1){ref-type="supplementary-material"}). As a control, we used an otherwise isogenic strain that also has two FRT sites in the sub-telomeric region of the VII-L chromosome ([Fig. 1a](#F1){ref-type="fig"}), but in which FLP action does not affect the length of the VII-L telomere[@R4] ([Supplementary Fig. 1](#SD1){ref-type="supplementary-material"}, left).

The experimental and control strains, which expressed the same epitope tagged protein, were arrested in parallel in late G1 phase by incubation with the yeast pheromone alpha factor. Galactose was added to the G1 arrested cells to induce FLP, and the extent of recombination was assessed by Southern analysis ([Supplementary Fig. 1](#SD1){ref-type="supplementary-material"}). After recombination, cells were released from G1 arrest and followed through the subsequent synchronous cell cycle[@R8]. Samples were taken at regular intervals and processed for chromatin immuno-precipitation (ChIP) to determine the association of the epitope tagged protein with the VII-L telomeres and fluorescent activated cell sorting (FACS) to assess cell cycle position. As an additional control, we examined association of epitope tagged proteins with the chromosome VI-R telomere, which is of WT length in both the experimental and control strains.

The profiles of telomere binding were very similar for each of the MRX subunits ([Fig. 1b,c](#F1){ref-type="fig"}). At the WT length VII-L telomere in the control strain, binding was low throughout the cell cycle, although there was significant telomere binding for each subunit at the 60 min time point, coincident with the time of telomere replication ([Fig. 1b](#F1){ref-type="fig"}, filled squares; see Figure legends for *p*-values). Similarly low but significant binding of each MRX subunit was detected at the WT VI-R telomere in both the experimental (open triangles) and control (closed triangles) strains ([Fig. 1c](#F1){ref-type="fig"}). However, each MRX subunit showed robust binding to the short VII-L telomere ([Fig. 1b](#F1){ref-type="fig"}, open squares). This binding was significant even in S phase but increased dramatically as cells neared the end of the cell cycle. Binding of each MRX subunit was four to six times higher to the short VII-L telomere than to the WT length VII-L telomere in the control strain or to the VI-R telomeres in either the control or experimental strain. Xrs2-MYC binding remains high for at least two cell cycles after telomere shortening ([Fig. 1d](#F1){ref-type="fig"}). Since the carboxyl end of Xrs2 is required for Tel1 telomere binding[@R8], the preferential binding of Xrs2 to the short VII-L telomere can explain the preferential binding of Tel1 to these ends.

Mec1 does not bind short telomeres even in *tel1Δ* cells {#S3}
--------------------------------------------------------

Telomeres can be maintained by telomerase in *tel1Δ* cells as long as *MEC1* is present[@R17]. To determine if Mec1, like Tel1, binds preferentially to short telomeres, we introduced three HA epitopes into an internal region of the protein (Mec1-HA[@R18]). As with the MRX experiment ([Fig. 1](#F1){ref-type="fig"}), cells were arrested with alpha factor, and Mec1 association with telomeres was determined throughout the cell cycle in both the control and experimental strains ([Fig. 2](#F2){ref-type="fig"}).

Mec1-HA binding to the short (open squares) and WT (closed squares) length VII-L telomeres was indistinguishable ([Fig. 2a](#F2){ref-type="fig"}). Binding to both VII-L telomeres was at background levels early in the cell cycle and through much of S phase. As cells completed S phase, Mec1-HA binding increased modestly until at the end of the cell cycle, it was four-fold higher than at the non-telomeric *ARO1* control sequence. Thus, although Mec1-HA binds to both the control and experimental VII-L telomeres, it does not bind preferentially to short telomeres.

We also examined Mec1 binding to two WT length telomeres, VI-R (open triangles) and XV-L (open circles) ([Fig. 2b](#F2){ref-type="fig"}). Since the pattern and extent of Mec1-HA binding to the two telomeres was indistinguishable in the two strains, only the data for the experimental strain are shown. This binding was indistinguishable from Mec1-HA binding to the non-telomeric *ARO1* locus to which the values are normalized. Although Mec1-HA binding to the short VII-L telomere was modestly higher than to the VI-R or XV-L telomeres, this difference was significant only at the 75 min (*p*= 0.01) and 90 min (*p*= 0.03) time points. Thus, significant Mec1-HA binding was detected only at telomeres that were acted upon by the FLP recombinase, and even this binding was significant only at two time points.

We also examined Mec1-HA binding to the short and WT length VII-L telomeres in *tel1Δ* cells where Mec1 is essential for telomere maintenance ([Fig. 2c](#F2){ref-type="fig"}). Mec1-HA binding was not detectable at either the control or experimental VII-L telomere in *tel1Δ* cells ([Fig. 2c](#F2){ref-type="fig"}). These data suggest that the low Mec1-HA binding to the FLP-generated short and WT length VII-L telomeres was a Tel1-mediated response and likely due to FLP-mediated DSB breakage at individual FRT sites in the absence of synapsis[@R19]. Finally, in the experimental strain, Tel1 binding to the short VII-L or WT VI-R telomere was not significantly higher in the absence of Mec1 ([Fig. 2d](#F2){ref-type="fig"}).

Mec1 binding is much higher at DSBs than at short telomeres {#S4}
-----------------------------------------------------------

To serve as a positive control for detecting Mec1 at telomeres ([Fig. 2a](#F2){ref-type="fig"}), we determined levels of Mec1 binding at an induced DSB, which is known to bind Mec1[@R20]--[@R23]. For these experiments, we used strains that were isogenic to the short telomere strain except they contained a galactose-inducible *HO* endonuclease instead of a galactose-inducible FLP recombinase and a recognition site for the *HO* endonuclease \~13 kb from the VII-L telomere and no chromosomal FLP sites[@R24]. Two different DSB strains were used ([Fig. 3a](#F3){ref-type="fig"}): TG80-HO contained 80 bp of TG~1--3~ telomeric DNA adjacent to the *HO* site, while N80-HO had 80 bp of unrelated DNA adjacent to the *HO* site[@R24].

Cells expressed the same Mec1-HA construct and were synchronized in the same manner as in the short telomere experiments with *HO* expression induced in G1 arrested cells and turned off before cells were allowed to progress through the cell cycle ([Fig. 2](#F2){ref-type="fig"}; [Supplementary Fig. 2](#SD1){ref-type="supplementary-material"}). As expected, Mec1-HA did not associate with the *HO* site in either strain in the absence of *HO* expression ([Fig. 3b](#F3){ref-type="fig"}, (-gal) time point). However, in both strains, Mec1-HA associated strongly and to a similar extent and duration with the *HO* induced breaks: binding was 20-fold over background in late G1 phase, increased to 80-fold at late S/G2 phase, and peaked at 140-fold by the end of the cell cycle. Thus, Mec1-HA binding was similarly high whether the DSB was adjacent to telomeric or non-telomeric DNA, and binding was much higher than binding to short telomeres (compare [Fig. 2a](#F2){ref-type="fig"} to [Fig. 3b](#F3){ref-type="fig"}).

We also examined Cdc13 binding to the induced TG80 and N80 DSBs ([Fig. 3](#F3){ref-type="fig"}). Cdc13 binding was not detectable before *HO* cleavage in either strains (-gal). In the TG80 break, Cdc13 binding was detectable even in G1 phase (0 min time point) and increased as cells progressed through the cell cycle, peaking at \~400 fold compared to binding to the *ARO* control sequence late in the cell cycle ([Fig. 3e](#F3){ref-type="fig"}, open circles). This level of Cdc13 binding is very similar to the level of Cdc13 binding detected at both short and wild type length telomeres in late S/G2 phase in a congenic strain that has been synchronized and analyzed in the same manner[@R8]. In contrast, Cdc13 binding to the N80 DSB was much lower, peaking at about 12 fold higher than the control ([Fig. 3e,f](#F3){ref-type="fig"} closed circles; **3f** scale is expanded compared to **e**). Using asynchronous cultures, Cdc13 binding to the TG80 DSB[@R12],[@R25] and to a non-telomeric, non-repairable DSB has been reported previously[@R26].

RPA and γH2AX do not bind preferentially to short telomeres {#S5}
-----------------------------------------------------------

RPA, a heterotrimeric complex that binds in a sequence non-specific manner to single strand DNA, is essential for DNA replication, repair, and recombination[@R27]--[@R28]. Because RPA is recruited to DSBs[@R29]--[@R31] and is suggested to have a role in telomerase recruitment[@R32], we examined its association with DSBs in the induced *HO* break system and with telomeres in the short telomere assay using synchronized cells and the same epitope tagged version of its largest subunit, Rfa1-MYC, in both experiments.

The signal in our telomere ChIPs is usually normalized to the amount of non-telomeric *ARO1* DNA in the same immuno-precipitate (IP). However, Rfa1-MYC should bind to every nuclear DNA sequence during its time of replication, including *ARO1*. As *ARO1* and telomeres replicate at different times in the S phase, the data for Rfa1-MYC binding are presented as percentage IP in both the induced DSB ([Fig. 3](#F3){ref-type="fig"}) and short telomere experiments ([Fig. 4](#F4){ref-type="fig"}).

In both the N80-HO (closed circles) and TG80-HO strains (open circles), Rfa1-MYC binding was not detected at the *HO* recognition site before *HO* expression ([Fig. 3c](#F3){ref-type="fig"}). However, Rfa1-MYC was DSB associated throughout the cell cycle with low binding in G1 phase that increased as cells progressed through the cell cycle. Although robust Rfa1-MYC binding was seen at both DSBs, at most time points, Rfa1-MYC binding was about two times higher at the N80-HO break than at the TG80-HO break, which is adjacent to telomeric sequence. In contrast, Rfa1-MYC binding to the internal *ARO* locus was low throughout the cell cycle except at the 45 min time point when binding was similarly high in the two DSB strains but much lower than to the DSB in the same cells ([Fig. 3d](#F3){ref-type="fig"}).

Using the induced telomere assay, we examined the association of Rfa1-MYC with three telomeres, VII-L ([Fig. 4a](#F4){ref-type="fig"}), VI-R ([Fig. 4b](#F4){ref-type="fig"}, open triangles) and XV-L ([Fig. 4b](#F4){ref-type="fig"}, open circles) in both the experimental and control strains. Because the data for the VI-R and XV-L telomeres were identical in the two strains (data not shown), only the data from the experimental strain are shown for these telomeres. In both strains, Rfa1-MYC binding to the three WT length and the short VII-L telomeres occurred during a discrete interval in late S phase, peaking at 60 min, consistent with the expected time of telomere replication ([Fig. 4a,b](#F4){ref-type="fig"}). Rfa1-MYC binding to the *ARO1* locus also occurred during a limited but earlier period in S phase ([Fig. 4c](#F4){ref-type="fig"}), and its timing and extent of binding was similar to what was seen in the DSB strains ([Fig. 3d](#F3){ref-type="fig"}). The level of Rfa1-MYC binding to the three WT length telomeres and to the *ARO1* locus was similar, ranging from 0.25% (*ARO1*) to 0.37% (telomere VI-R). The level of binding to the short VII-L telomere was modestly higher late in the cell cycle compared to WT VII-L, but this difference was not significant. Moreover, Rfa1-MYC binding to telomeres was \~5--9 times lower at telomeres than at DSBs (compare [Fig. 4a](#F4){ref-type="fig"} to [3c](#F3){ref-type="fig"}; maximal binding to telomeres was 0.5% while binding to the N80-HO and the TG80-HO breaks was, respectively, 4.5% and 2.3%). Thus, preferential binding of RPA to short telomeres is unlikely to mark them for preferential lengthening by telomerase as suggested by earlier work[@R32].

An early response to DNA damage is the replacement of canonical H2A by an H2A variant called H2AX, which is then phosphorylated (referred to as γ-H2AX)[@R33]. Since the sole version of H2A in yeast is analogous to the H2AX of other eukaryotes, yeast H2A is phosphorylated rather than replaced upon DNA damage[@R34]. Because telomeres have high γ-H2AX levels[@R35]--[@R36], we asked if this modification marks short telomeres for telomerase elongation. Using the inducible short telomere assay, we determined levels of γ-H2AX at the short and control VII-L telomeres, at two native WT length telomeres (VI-R and XV-L), and at two non-telomeric loci (*ARO1* and *RPL11A*) in both the control and experimental strains ([Fig. 4d -- f](#F4){ref-type="fig"}). As with the Rfa1-MYC data ([Fig. 4a -- c](#F4){ref-type="fig"}), γ-H2AX values are presented as percent target sequence in the immuno-precipitate (Percentage IP).

For all loci, the level of γ-H2AX was fairly constant from late G1 phase through the end of the cell cycle, with a very modest decline after S phase ([Fig. 4d -- f](#F4){ref-type="fig"}). The level of γ-H2AX at the VII-L telomere was not affected by telomere length ([Fig. 4d](#F4){ref-type="fig"}: open squares, short telomere; closed squares, WT length VII-L telomere; the only significant difference is at 75 min; *p*= 0.04). However, the levels of γ-H2AX at both VII-L telomeres were about twice as high as at either telomere VI-R or XV-L suggesting that FLP action increases γ-H2AX levels ([Fig. 4e](#F4){ref-type="fig"}) (as well as Mec1-HA binding; [Fig. 2b](#F2){ref-type="fig"}). Nonetheless, H2A phosphorylation does not mark short telomeres for preferential elongation by telomerase.

Loss of Rif2, not Rif1, occurs as telomeres shorten {#S6}
---------------------------------------------------

When telomeres are shortened by internal deletion as they are in the inducible short telomere system ([Fig. 1a](#F1){ref-type="fig"}), Rif2 content is lower at short than at WT telomeres, while Rif1 levels are similar at both[@R8]. We wished to test the model that depletion of Rif2 is the signal that marks short telomeres for preferential telomerase elongation. However, first it was important to determine if telomeres shortened from their ends by incomplete replication, the normal mechanism of telomere shortening, show the same chromatin composition as telomeres shortened by FLP-mediated internal deletion. We constructed diploids that were homozygous for either Rif1-MYC, Rif2-MYC, or Yku80-MYC and heterozygous for a deletion of *TLC1*, the telomerase RNA gene ([Fig. 5a](#F5){ref-type="fig"}). Diploids were sporulated, tetrads were dissected and individual *tlc1Δ* or *TLC1* spore clones were grown for a total of \~25--30 generations until the *tlc1Δ* telomeres had shortened to \~150 bps ([Supplementary Fig. 3](#SD1){ref-type="supplementary-material"}). The same samples were examined by ChIP to assess levels of Rap1 (using a polyclonal anti-Rap1 serum) or MYC-tagged proteins at both the VI-R and XV-L telomeres ([Fig. 5b -- e](#F5){ref-type="fig"}).

At both the VI-R and XV-L telomeres, Yku80-MYC ([Fig. 5b](#F5){ref-type="fig"}) and Rif1-MYC ([Fig. 5c](#F5){ref-type="fig"}) levels were indistinguishable at WT length and shortened telomeres (see [Fig. 5](#F5){ref-type="fig"} legends for *p*-values). However, Rap1 binding at short telomeres was reduced (66%, telomere VI-R; 58%, XV-L) ([Fig. 5d](#F5){ref-type="fig"}). Rif2 levels were also lower at the short VI-R (65% of WT levels) and XV-L (21% of WT) telomeres ([Fig. 5e](#F5){ref-type="fig"}).

Preferential Tel1 binding to short telomeres requires Rif2 {#S7}
----------------------------------------------------------

If Rif2 depletion is the signal that marks short telomeres for elongation, the ability of Tel1 to distinguish between short and WT length telomeres might be compromised in *rif2Δ* but not *rif1Δ* cells ([Fig. 6](#F6){ref-type="fig"}). To test this possibility, we constructed diploid strains that were heterozygous for a deletion of both *TLC1* and for either *RIF1* or *RIF2*. Both haploid parents also expressed Tel1-HA. Diploids were sporulated, tetrads were dissected, and individual *tlc1Δ* spore clones that were either WT, *rif1Δ*, or *rif2Δ* were grown for a total of \~25--30 generations to an average telomere length of \~150 bps (as in [Supplementary Fig. 4](#SD1){ref-type="supplementary-material"}). After immuno-precipitating the samples with anti-HA to precipitate Tel1-HA associated DNA, both immuno-precipitate and input DNA were subjected to telomere PCR and then gel electrophoresis to determine telomere sizes (see [Fig. 6b](#F6){ref-type="fig"} for representative gels). We examined the lengths of both telomeres VI-R and XV-L in the anti-Tel1 immuno-precipitates. Because the sizes of individual telomeres change in a stochastic manner[@R37], we compared telomere lengths pre and post-immuno-precipitation from a given spore clone. The data are presented as the average percent decrease in length of the Tel1 immuno-precipitate sample compared to that of the input DNA for the individual spore clones examined ([Fig. 6c](#F6){ref-type="fig"}).

As expected, in WT cells, Tel1 bound preferentially to short telomeres as the average length of telomeres was shorter in the Tel1 immuno-precipitate than in the input sample (26% shorter for telomere VI-R; 45% shorter for telomere XV-L) ([Fig. 6c](#F6){ref-type="fig"}, VI-R, white bar; XV-L, solid bar). Very similar results were obtained in *rif1Δ* cells where the DNA in the anti-Tel1 immuno-precipitate was 25% (telomere VI-R) and 44% (telomere XV-L) shorter than in the input samples ([Fig. 6c](#F6){ref-type="fig"}, VI-R, white bar; XV-L, solid bar). When the same experiment was done with *rif2Δ* cells ([Fig. 6c](#F6){ref-type="fig"}, VI-R, white bar; XV-L, solid bar), telomeres in the Tel1-HA immuno-precipitate were still shorter than in the input DNA, but the effect was greatly attenuated (11% shorter for telomere VI-R; 14% shorter for telomere XV-L). Indeed, in *rif2Δ* cells, the difference in length between the input and immuno-precipitated DNA samples was not significant for either telomere (VI-R, *p*= 0.377; XV-L, *p*= 0.218). The average percent difference in length for *rif2Δ* cells was significantly different from both WT (VI-R, *p*= 0.002; XV-L, \<10^−4^) and *rif1Δ* (VI-R, *p*= 0.008; XV-L, *p*= 0.0003) at both telomeres while the differences between *rif1Δ* and WT cells were not significant (VI-R, *p*= 0.699; XV-L, *p*= 0.814). These data support a model in which reduced Rif2 content is a signal that marks short telomeres for preferential Tel1 binding and telomerase elongation.

Discussion {#S8}
==========

A short telomere generated by an internal deletion ([Fig. 1a](#F1){ref-type="fig"}) is lengthened at a faster rate than a WT length telomere for multiple cell cycles after shortening[@R4]. Here we show that Mre11, Rad50, and Xrs2 each bound preferentially to these short telomeres ([Fig. 1b](#F1){ref-type="fig"}). In contrast, RPA ([Fig. 4a](#F4){ref-type="fig"}) and γ-H2AX ([Fig. 4d](#F4){ref-type="fig"}) associated equally well with short and WT length telomeres while Mec1 binding was very low at all telomeres ([Fig. 2a -- c](#F2){ref-type="fig"}). These results differ from those from another lab that showed robust Mec1 binding and low Tel1 binding to bulk telomeres in late S/G2 phase[@R38]--[@R39]. In a *tel1Δ* strain where Mec1 is essential for telomerase action[@R13]--[@R14], no Mec1 telomere binding was detected ([Fig. 2c](#F2){ref-type="fig"}). As a positive control, we monitored Mec1 binding to a DSB in an identical experimental situation and found that it was ≥140-fold higher than to a short telomere in the first cell cycle after telomere shortening or break induction (compare [Fig. 2c](#F2){ref-type="fig"} and [3b](#F3){ref-type="fig"}). Since levels of Cdc13 binding to the TG80 DSB ([Fig. 3e](#F3){ref-type="fig"}) were similar to levels of Cdc13 at short and WT length telomeres[@R8], the ability to detect Mec1 at DSBs but not at telomeres was not due to the DSB being a better substrate for ChIP. In contrast to Mec1, Tel1 binding to short telomeres is extremely robust[@R8]. Mec1 must either bind very transiently and/or to only a small subset of telomeres or act by phosphorylating its targets when they are not telomere associated. The fact that telomeres are much shorter in *tel1Δ* compared to wild type cells indicates that Mec1 is less efficient than Tel1 at promoting telomerase-mediated telomere lengthening, behavior that can be explained by its extremely low telomere binding.

Est2 and Est1 do not bind preferentially to the inducible short VII-L telomere in the absence of Tel1 or in an *xrs2-664* mutant that lacks the portion of the protein that interacts with Tel1 at DSBs[@R8]. Moreover, short telomeres are not processively lengthened in *tel1Δ* cells[@R7]. Therefore, the preferential binding of the MRX complex to short telomeres ([Fig. 1b](#F1){ref-type="fig"}) is sufficient to explain how Tel1 and hence Est2 and Est1 act preferentially at short telomeres. MRX is not brought to short telomeres by differential Mec1, RPA, or γ-H2aX levels, as these proteins were either absent (Mec1) or equally abundant at short and WT length telomeres ([Fig. 2a](#F2){ref-type="fig"}, [Fig. 4a -- d](#F4){ref-type="fig"}).

Since Rif2 was distributed differently on short versus WT length telomeres ([Fig. 5](#F5){ref-type="fig"}; see also [Fig. 6d](#F6){ref-type="fig"}), we asked if Rif2 is important to direct Tel1 to short telomeres by determining the lengths of telomeres in anti-Tel1 immuno-precipitates from WT, *rif1Δ* and *rif2Δ* cells ([Fig. 6](#F6){ref-type="fig"}). Telomeres in the anti-Tel1 immuno-precipitates were \~25% (telomere VI-R) or \~45% (telomere XV-L) shorter than bulk telomeres in both WT and *rif1Δ* cells. Since Tel1 still bound preferentially to short telomeres in *rif1Δ* cells, Rif1 must inhibit telomerase at a step downstream of Tel1 binding. In contrast, in *rif2Δ* cells, the sizes of both the VI-R and XV-L telomeres were not significantly different in the anti-Tel1 immuno-precipitate compared to input DNA ([Fig. 6c](#F6){ref-type="fig"}). Thus, in the absence of Rif2, Tel1 was unable to distinguish short from WT length telomeres. These data suggest that differential distribution of Rif2 on short versus WT length telomeres is required to direct MRX, Tel1, and telomerase to short telomeres. *In vitro* studies reveal that Rif2 (but not Rif1) interacts with the carboxyl terminus of Xrs2, and this interaction can prevent Xrs2 from interacting with Tel1[@R12]. Thus, as telomeres shorten and lose Rif2, MRX should be more effective at recruiting Tel1.

Rif1 and Rif2 must inhibit telomerase by different mechanisms as Rif1 levels were the same at WT (\~300 bps) and short (\~150 bps) telomeres. Rif1 has 14 S/TQ sites, which are recognition sites for ATM kinases, while Rif2 has none. Rif1 is phosphorylated on at least one of these sites *in vivo*[@R40]. An appealing model is that telomere-associated Rif1 is phosphorylated by Tel1, and this phosphorylation reduces its inhibition of telomerase. In addition, the loss of Rif2 but not Rif1 as telomeres shorten from \~300 to \~150 bps ([Fig. 5](#F5){ref-type="fig"}) suggests that the two proteins are distributed differently along the yeast telomere with Rif1 positioned centromere proximal to Rif2 ([Fig. 6d](#F6){ref-type="fig"}). Earlier studies are consistent with the idea that Rif1 and Rif2 act by different mechanisms and also suggest that Rif2 is more potent than Rif1 at inhibiting telomerase[@R12],[@R41].

The data in this paper are relevant to an understanding of how cells distinguish telomeres from DSBs. The early events in DSB processing and telomerase-mediated lengthening are remarkably similar. At both, MRX binds and recruits Tel1, and at both, DNA resection occurs via the collaborative and partially overlapping actions of Sae2, Exo1, and Sgs1[@R42]--[@R44]. However, because DSBs occur throughout the genome, the resection-generated 3′ single strand tails at these ends are not sequence specific whereas the \~50--100 base long resection-generated telomeric 3′ tails are exclusively TG~1--3~ DNA. We confirmed that DSBs are RPA-associated, even when the break was next to an internal tract of telomeric DNA ([Fig. 3c](#F3){ref-type="fig"}). In contrast, at telomeres, single strand tails are Cdc13-associated[@R45]. Although RPA was detected at telomeres late in the S phase, this binding was not higher at the short versus control VII-L telomere ([Fig. 4a](#F4){ref-type="fig"}). The most likely explanation for this telomeric RPA is that it occurs during semi-conservative replication of telomeric DNA. Although we cannot exclude the possibility that there is some RPA binding to the resection-generated TG~1--3~ tails, there was \~8-times more RPA at DSBs than at telomeres ([Fig. 3c](#F3){ref-type="fig"}). Likewise, Mec1 binding was essentially undetectable at short telomeres while it bound robustly to DSBs. The fact that RPA recruits Mec1 to resected DSBs[@R46]--[@R47] yet Mec1 was not at telomeres provides further evidence that the low level of RPA seen at telomeres was associated with conventional forked replication intermediates rather than bound to resection-generated TG~1--3~ tails.

Mec1 binding was similarly high at the TG80-HO and N80-HO DSBs ([Fig. 3b](#F3){ref-type="fig"}), a different result from that in earlier studies that found much lower Mec1 binding when a break is adjacent to an internal tract of telomeric DNA[@R21],[@R25]. However, these earlier studies used asynchronous cells and examined Mec1 binding at 1 to 6 hrs after inducing the DSB. In our study, the DSB was introduced in G1 arrested cells, and the nuclease turned off and cells released into the cell cycle only after most of the cells had an *HO*-induced DSB ([Supplementary Fig. 2](#SD1){ref-type="supplementary-material"}). Thus, in our experiments, RPA and Mec1 binding to the DSB were examined during the first cell cycle after break formation, before checkpoint-mediated arrest ([Fig. 3b](#F3){ref-type="fig"}). Since the cell cycle arrest is not as lengthy when a DSB is adjacent to telomeric DNA[@R48], the difference between the two experiments is likely explained by the different protocols used to detect Mec1 binding. Although there was high RPA association with the TG80-HO break, the level of RPA association was decreased by about 50% at this break than at N80-HO ([Fig. 3c](#F3){ref-type="fig"}), perhaps because Cdc13 competes with RPA for binding to the TG~1--3~ tails generated by resection of the TG80-HO break ([Fig. 3](#F3){ref-type="fig"}) or inhibits resection of the DSB (or both).

In mammals[@R49]--[@R50] and yeasts, the processes that occur at DSBs and replicating telomeres are similar. Although a single short yeast telomere can trigger at least one step in the DNA damage signaling cascade, Rad53 phosphorylation[@R51], it does not elicit a checkpoint mediated cell cycle arrest as, by several criteria, the cell cycle following its induction is of normal length[@R8]. In contrast, a single DSB elicits a strong checkpoint response[@R52]. Our data suggest that the lack of cell cycle arrest in response to a short telomere is due to the fact that resected telomeres are coated by Cdc13, not RPA, and hence do not recruit Mec1, whose presence is necessary to trigger a full checkpoint response.

Methods {#S9}
=======

(Detailed methods are available in [Supplementary Information](#SD1){ref-type="supplementary-material"}).

Yeast strains are listed in [Supplementary Table 1](#SD1){ref-type="supplementary-material"} {#S10}
--------------------------------------------------------------------------------------------

The inducible short telomere experiments were carried out in *bar1Δ*∷*KAN1*[@R54] derivatives of the W303 strain Lev220[@R4]. Tel1 and Mec1 were internally tagged with three HA epitopes as in[@R18]. Mre11, Rad50, Xrs2, and Rfa1 were tagged at their C-termini with thirteen MYC epitopes. Cdc13 was tagged at its C-terminus with nine MYC epitopes[@R45]. *TEL1* was deleted in the Mec1-HA strain and replaced with *HIS3*. The DSB experiments were performed in derivatives of W303 strains analogous to those in ref.[@R24] (YAB285 and YAB1083) that contained *bar1Δ*∷*NAT* (and *sml1Δ*∷*HIS3* in the Mec1-HA strains). These strains contain a galactose-inducible *HO* gene at the *leu2* locus on chromosome III and a modified chromosome VII-L in which an *HO* endonuclease recognition site was between the *ADH4* and *MNT2* loci, as described[@R24]. TG80-HO strains contain 80 bp of TG~1--3~ repeats on the centromere-proximal side of the *HO* recognition site; in N80-HO strains, this 80 bp sequence is replaced with 80 bp of lambda DNA.

Experiments to determine protein composition of telomeres shortened from their ends used spore clones obtained from sporulation of *tlc1Δ*∷*LEU2/TLC1* diploids that were homozygous for MYC tagged *RIF1*, *RIF2*, or *KU80*, with tagging done as described previously[@R8]. *tlc1Δ*∷*LEU2* and *TLC1* spores clones carrying the appropriate tagged genes were grown for 25--30 generations in log phase growth before determining telomere length by Southern blot analysis and protein content by ChIP. To determine the effects of *RIF* genes on Tel1 binding to telomeres of different lengths, diploids homozygous for Tel1-HA and heterozygous for *tlc1Δ*, *rif1Δ* and *rif2Δ* were sporulated and spore clones were grown for a total of \~25--30 generations and processed for ChIP.

Synchrony methods {#S11}
-----------------

Galactose induction and cell synchronization in both the induced short telomere and induced DSB strains were done essentially as described[@R8]. Samples were taken at least every 15 min and processed for flow cytometry, Southern blot analysis to determine percent recombination or percent DSB formation, and ChIP.

Telomere PCR {#S12}
------------

Samples were processed for telomere PCR using minor modifications of the methods described in[@R10]. The primers used in this study are listed in [Supplementary Table 2](#SD1){ref-type="supplementary-material"} The PCR products were resolved on a 3% (w/v) MetaPhor (Lonza) agarose gel using 1 Kb Plus DNA Ladder as a marker (Invitrogen). The lengths of the telomere PCR products were determined by the AlphaImager 3400 Molecular Weight Analysis program. For all experiments, an aliquot of the telomere PCR products were gel-purified, cloned and sequenced to verify that they contained telomeric repeats. Of the 100 sequenced clones, 90% contained telomeric DNA while 10% had no insert.

Chromatin immuno-precipitation (ChIP) {#S13}
-------------------------------------

All ChIPs were performed as described[@R8],[@R55]--[@R56]. Anti-sera were anti-MYC (Clontech monoclonal Ab \#631206), anti-HA (Santa Cruz, monoclonal Ab \#SC7392X), anti-H2A phosphoS129 (Abcam polyclonal Ab \#ab15083) or an affinity purified polyclonal anti-Rap1 serum[@R57]. The amount of DNA in ChIP and input samples was quantitated using real-time PCR (BioRad iCycler). In most cases, percentage IP was normalized to the amount of the non-telomeric *ARO1* sequence in the immuno-precipitate and input samples. However, for the Rfa1-Myc and the γH2AX experiments, results are presented as percent immuno-precipitate (amount of target sequence in IP/amount in input sample).

Statistical Testing {#S14}
-------------------

For all ChIP experiments, samples from each time point were amplified in duplicate or triplicate to obtain an average value for each sample. Each synchrony was repeated at least three times. For determining protein content at telomeres shortened from their ends, ChIPs were carried out on three or more independent spore clones for each genotype. Data are presented as the mean plus or minus one standard deviation, and a two-tailed Student's *t*-test was used to determine statistical significance. A *p*-value ≤ 0.05 was considered significant.
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======================
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![MRX binds preferentially to short telomeres\
(**a**) Schematic short telomere assay: structures of VII-L end before (parental) and after FLP recombination in experimental (left) and control (right) strains. Recombination generates VII-L telomere with \~100 bp telomeric DNA in experimental strain (short) or \~300 bps (WT) telomere in control strain. Restriction enzyme sites: *Xho*I (X), *Stu*I (S), *Eco*RV (V), *Pst*I (P), *Hind*III (H). (**b**) Experimental and control strains expressing Mre11-MYC, Rad50-MYC, or Xrs2-MYC were arrested, FLP was induced, and cells were removed from both alpha factor and galactose (0 min), and proceeded through synchronous cell cycle. Filled and open squares indicate, respectively, average fold enrichment of tagged protein ± one standard deviation to short (open) or WT (closed) VII-L telomere compared to binding to non-telomeric *ARO1* locus in same sample. Fold enrichment scale is not the same on three panels. (**c**) Using same samples as in panel **b**, binding of indicated protein to WT length VI-R telomere was determined in experimental (open triangles) and control (closed triangles) strains. Scale for fold enrichment is different from other panels. Binding of each protein to VI-R telomeres in two strains was not significantly different at any time point (*p*-values all ≥ 0.12). (**d**) Xrs2 binds preferentially to short telomeres for at least two cell cycles. Experimental strain expressing Xrs2-MYC was synchronized. Samples were taken over two cell cycles and processed for ChIP. Average levels Xrs2-MYC binding to short VII-L (open squares) and WT length VI-R (open triangles) telomeres are shown.](nihms234684f1){#F1}

![Mec1-HA does not bind preferentially to short telomeres, even in *tel1Δ* cells\
The control and experimental strains expressing Mec1-HA (**a--c**) or Tel1-HA (**d**) were synchronized and processed as described ([Fig. 1](#F1){ref-type="fig"}). (**a**) Mec1-HA binding to the VII-L telomeres occurred at low levels at 60, 75 and 90 mins. The timing and level of Mec1-HA binding to the short VII telomere (open squares) and the WT length VII-L telomere (closed squares) were indistinguishable at all time points (*p*-values from 0.19 to 0.96). (**b**) Mec1-HA binding to the WT length VI-R and XV-L telomeres was indistinguishable from binding to the short VII-L telomere (taken from panel **a** and shown for comparison) except at 75 and 90 min (*p*= 0.01 and 0.03). Only data from the experimental strain are shown. (**c**) The experiment in panel **a** was carried out in *tel1Δ* versions of the control and experimental strains expressing Mec1-HA. Binding to the short and WT length VII-L telomeres was indistinguishable from binding to the non-telomeric *ARO1* locus in the same samples (to which the values are normalized). (**d**) Experiments to determine if Tel1-HA binding is affected by absence of Mec1 were done in *sml1Δ* derivative of the WT and *mec1Δ* strains[@R53]. Tel1-HA binding to the short VII-L telomere or to the WT VI-R telomeres (panel **d**) was indistinguishable in *sml1Δ* (MEC1) and *mec1Δ* *sml1Δ* (mec1) cells (*p*-values from 30 to 90 min were 0.08 to 0.84).](nihms234684f2){#F2}

![Mec1 and Rfa1 bind DSBs, even when the break is adjacent to telomeric DNA\
(**a**) Schematic of chromosome VII-L end in DSB strains[@R24]. TG80-HO contains 80 bp TG~1--3~ on centromere side of *HO* site; N80-HO contains 80 bp lambda DNA. V (*Eco*RV) sites (**b**) Mec1-HA binding to DSBs. For **b, c**, cells were synchronized and processed as described in ([Fig. 1](#F1){ref-type="fig"}) except an extra sample was taken from G1 arrested cells before addition of galactose. Mec1 binding was determined at N80-HO (closed circles) and TG80-HO (open circles) before and after *HO* induction. Results are average fold enrichment ± one standard deviation over binding to control site *ARO1*. (**c**) Rfa1-MYC binding to DSBs. Rfa1-MYC binding was determined at N80-HO (closed circles) and TG80-HO (open circles) before and after induction of *HO*. Results are average percent of DNA in input. Rfa1-MYC binding to N80-HO was higher than at TG80-HO break (*p*-values 0.00037 to 0.017), in all post-galactose samples except the 45 min time point (*p*= 0.093). (**d**) Samples used in panel **c** were examined for Rfa1-MYC binding to internal *ARO* locus in both TG80 (open triangles) and N80 (closed triangles) strains. The level and timing of Rfa1-MYC binding was equivalent in the two strains. (**e**) Cdc13-MYC binding to TG80 (open circles) and N80 (closed circles) in first cell cycle after breakage. (**f**) The same samples in panel e for the N80 strain are shown with expanded scale.](nihms234684f3){#F3}

![Rfa1 binding and H2A phosphorylation are similar at short and WT telomeres\
Rfa1-MYC cells were treated as in ([Fig. 1](#F1){ref-type="fig"}) or immuno-precipitated with anti-γ H2Aserum (Panels **d--f**). Data are average percent immuno-precipitated DNA ± one standard deviation. (**a**) Rfa1-MYC binding to short and WT length VII-L telomeres. Average enrichment at short VII-L was modestly higher than for WT VII-L but difference was only significant at 37.5 min (*p*= 0.02; *p*-values for other time points were 0.08 to 0.42). Rfa1-MYC binding occurred at time of telomere replication (60--75 min). (**b**) Rfa1-MYC binding to short VII-L telomere (open squares; data are from panel **a**), WT length VI-R (open triangles) and XV-L (open circles) telomeres in experimental strain was indistinguishable except at early points (*p*-values for 45--90 min 0.03 to 0.45). Data from control strain are also indistinguishable (*p*-values 0.17 to 0.98) from binding in experimental strain. (**c**) Rfa1-MYC binding to *ARO1* locus is same in experimental (open triangles) and control (closed triangles) strains (*p*-values 0.19 to 0.95). (**d**) H2A phosphorylation was similar at short (open squares) and WT length (closed squares) VII-L telomeres except at 75 min (*p*= 0.04). (**e**) γ-H2AX levels at VI-R and XV-L telomeres are constant throughout cell cycle. Binding to telomeres is shown only for the experimental strain but values for both telomeres were indistinguishable in the control versus experimental strains (*p*= 0.08 to 0.98). (**f**) γH2A phosphorylation at *RPL11A* (diamonds) and *ARO1* (triangles) in experimental strain.](nihms234684f4){#F4}

![Rif2 (and Rap1) but not Rif1 or Yku80 occupancy are reduced at short telomeres\
(**a**) Schematic of assay. (**b--e**) Rif2 but not Rif1 content is lower at short versus WT length telomeres. Samples from three (Yku80 and Rap1) or five (Rif1 and Rif2) independent *TLC1* or *tlc1Δ* spore clones were subjected to ChIP after \~25--30 generations of spore outgrowth. Samples expressing MYC-tagged proteins (panels **b--e**) were immuno-precipitated with an anti-Myc antibody. Samples from an untagged strain were immuno-precipitated with anti-Rap1 antibody (panel **d**). Purified DNA was analyzed by quantitative PCR to determine the level of protein binding to VI-R and XV-L telomeres. Data are expressed as the average fold enrichment of telomeric sequence over the non-telomeric *ARO1* sequence in the same immuno-precipitate. Error bars indicate one standard deviation from average. The differences between binding levels of Yku80 (*p*= 0.354, VI-R; 0.840, XV-L) and Rif1 (*p*= 0.731, VI-R; 0.492, XV-L) at WT and short telomeres were not significant. Binding levels of Rap1 (*p*= 0.026, VI-R; 0.009, XV-L) and Rif2 (*p*= 1.2×10^−3^, VI-R; 1.3×10^−6^, XV-L) were significantly different at WT and short *tlc1Δ* telomeres.](nihms234684f5){#F5}

![Preferential binding of Tel1 to short telomeres is lost in *rif2Δ* cells\
(**a**) Schematic of assay. (**b--c**) After \~30 cell generations, 3--9 independent spores from *tlc1Δ* *RIF1 RIF2, tlc1Δ* *rif1Δ*, and *tlc1Δ* *rif2Δ*, all expressing Tel1-HA, were subjected to ChIP with anti-HA antibody. Average length of telomeric DNA in each sample was determined (representative gels for telomere XV-L, panel **b**). Data are expressed as percent decrease in the average telomere length of the immuno-precipitate compared to length of input. Error bars, one standard deviation from mean. Percent differences correspond to the following average absolute differences in telomere length in input versus Tel1 immuno-precipitated DNA: WT: 38 (VI-R); 76 (XV-L) bps; *rif1Δ*: 33 bps (VI-R); 78 (XV-L); *rif2Δ*: 18 (VI-R); 26 (XV-L) bps. (**d**) Model for Rif1 and Rif2 distribution along telomere. WT length telomere (top) of \~300 bp C~1--3~A/TG~1--3~ duplex DNA contains \~17 Rap1 binding sites (not all are shown), and a short single strand TG~1--3~ tail. Short and WT telomeres contain equal number of heterodimeric Ku complexes and Cdc13-Stn1-Ten1 complexes. For simplicity, we show one Ku and one Cdc13 complex per telomere. Rif1 and Rif2 come to the telomere by interaction with Rap1. As telomeres shorten, they lose Rif2 before Rif1, suggesting that Rif1 is positioned centromere proximal to Rif2. Thus, 300 bp WT and 150 bp short telomere would have \~the same amount of Ku, Cdc13, and Rif1. The shorter telomere has \~50% of Rap1 and Rif2 levels as at WT telomere.](nihms234684f6){#F6}
